Skip to main content
Premium Trial:

Request an Annual Quote

Boehringer Ingelheim to Use ChemAxon's Cheminformatics Software for Drug Research

Premium

ChemAxon said this week that Boehringer Ingelheim will use its cheminformatics platform to store, search, and visualize chemical entities, properties, and reactions as part of its internal and external drug research and development efforts.

ChemAxon said that Boehringer chose its software after evaluating factors such as its return on investment, performance, robustness, and scalability.

Other pharmaceutical companies that use ChemAxon's software include Japan's Eisai, which licensed its JChem Cartridge database management and search tool (BI 1/6/2012); and Pfizer, which licensed its platform to help with Markush structure searching (BI 1/22/2010).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.